Market Tracker

11/25 6:05pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
7.08 +0.30 / +4.42%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.08 -0.0008 / -0.01%
 
Volume: 12.2K

Today’s Trading

Previous close6.78
Today’s open6.80
Day’s range6.64 - 7.14
Volume1,492,822
Average volume (3 months)980,309
Market cap$471.6M
Dividend yield--
Data as of 3:59pm ET, 11/25/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+115.79%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratio141.6
Price/Sales37.83
Price/Book5.22

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.02+0.19%
PETXAratana Therapeutics...-0.13-0.97%
SPPISpectrum Pharmaceuti...-0.02-0.27%
VTLVital Therapies Inc+0.54+2.82%
Data as of 3:59pm ET, 11/25/2014

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts